I agree that this site is using cookies. You can find further informations here.
X
Schettler, Volker J. J.
64  results:
Search for persons X
?
1

Evolocumab-Based LDL-C Management in High and Very High Car..:

Lehrke, Michael ; Vogt, Anja ; Schettler, Volker...
Advances in Therapy.  41 (2024)  3 - p. 1184-1200 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Effective exosomes reduction in hypercholesterinemic patien..:

Schröder, Sophie ; Epple, Robert ; Fischer, Andre.
Therapeutic Apheresis and Dialysis.  , 2024
Link: https://doi.org/10.1111/..
 
?
3

State of the Art: Lipoproteinapherese:

Schatz, Ulrike ; Schettler, Volker J.J. ; Julius, Ulrich
DMW - Deutsche Medizinische Wochenschrift.  148 (2023)  8 - p. e44-e54 , 2023
Link: https://doi.org/10.1055/..
 
?
4

Erratum: State of the Art: Lipoproteinapherese:

Schatz, Ulrike ; Schettler, Volker J.J. ; Julius, Ulrich
DMW - Deutsche Medizinische Wochenschrift.  148 (2023)  8 - p. e55-e55 , 2023
Link: https://doi.org/10.1055/..
 
?
5

Beyond cholesterol—pleiotropic effects of lipoprotein apher..:

Schettler, Volker J. J. ; Schettler, Elke
Therapeutic Apheresis and Dialysis.  26 (2022)  S1 - p. 35-40 , 2022
Link: https://doi.org/10.1111/..
 
?
6

Novel Insights into the Management of Patients with Very Hi..:

Laufs, Ulrich ; Birkenfeld, Andreas L. ; Fraass, Uwe...
Cardiovascular Drugs and Therapy.  38 (2022)  1 - p. 119-129 , 2022
Link: https://doi.org/10.1007/..
 
?
7

The German Lipoprotein Apheresis Registry—Summary of the ni..:

Schettler, Volker J. J. ; Peter, Christian ; Zimmermann, Thomas...
Therapeutic Apheresis and Dialysis.  26 (2022)  S1 - p. 81-88 , 2022
Link: https://doi.org/10.1111/..
 
?
8

Unverträglichkeit von Statinen:

Schettler, Volker J. J. ; Schettler, Elke
CardioVasc.  21 (2021)  3 - p. 23-24 , 2021
Link: https://doi.org/10.1007/..
 
?
9

With reasonable doubt: Plasma exchange in PEXIVAS:

Hohenstein, Bernd ; Schettler, Volker ; de Groot, Kirsten
Therapeutic Apheresis and Dialysis.  25 (2020)  1 - p. 128-129 , 2020
Link: https://doi.org/10.1111/..
 
?
10

Lipoprotein(a) – Marker for cardiovascular risk and target ..:

Klingel, Reinhard ; Heigl, Franz ; Schettler, Volker...
Atherosclerosis Supplements.  40 (2019)  - p. 17-22 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Real‐world study: Escalating targeted lipid‐lowering treatm..:

Spitthöver, Ralf ; Röseler, Tilmann ; Julius, Ulrich...
Journal of Clinical Apheresis.  34 (2019)  4 - p. 423-433 , 2019
Link: https://doi.org/10.1002/..
 
?
12

Lipoprotein apheresis in Germany – Still more commonly indi..:

Heigl, Franz ; Pflederer, Tobias ; Klingel, Reinhard...
Atherosclerosis Supplements.  40 (2019)  - p. 23-29 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Efficacy of lipid reduction with DALI and MONET:

Ramlow, Wolfgang ; Röseler, Eberhard ; Heigl, Franz...
Atherosclerosis Supplements.  30 (2017)  - p. 217-224 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Safety aspects of lipidapheresis using DALI and MONET – Mul..:

Kozik-Jaromin, Justyna ; Röseler, Eberhard ; Heigl, Franz...
Atherosclerosis Supplements.  30 (2017)  - p. 225-231 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Extrem niedrige LDL-Cholesterinkonzentrationen durch modern..:

Schettler, Volker J. J. ; Roeseler, E. ; Platzer, C....
CardioVasc.  17 (2017)  4 - p. 54-57 , 2017
Link: https://doi.org/10.1007/..
 
1-15